SYRS vs AMGN: Which Stock is Better?
Side-by-side comparison of Syros Pharmaceuticals Inc and Amgen Inc in 2026
SYRS
Syros Pharmaceuticals Inc
$0.00
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | SYRS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $0.01M | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | -0.0% | 0.1% | AMGN |
| Gross Margin | -22863.0% | 70.8% | AMGN |
Analyze SYRS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRS or AMGN a better investment?
Comparing SYRS and AMGN: Syros Pharmaceuticals Inc has a market cap of $0.01M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRS and AMGN?
SYRS (Syros Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRS or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRS or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.0% for SYRS.
Which company is more profitable: SYRS or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -22863.0% for SYRS.
Which is the larger company: SYRS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $0.01M for SYRS.
Should I buy SYRS or AMGN in 2026?
Both SYRS and AMGN have investment merit. SYRS trades at $0.00 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRS and AMGN stock?
Key differences: Market Cap ($0.01M vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (-22863.0% vs 70.8%).